Local Time : 11:12 CET

MC 728 - Hybrid imaging of the brain

Thursday, March 2, 14:00 - 15:30 Room: M 5 Session Type: Joint Course of ESR and RSNA (Radiological Society of North America): Hybrid Imaging Topics: Nuclear Medicine, Neuro, Hybrid imaging Moderators: A. Drzezga (Cologne/DE), K. Riklund (Umea/SE) Add session to my schedule In your schedule (remove)

A-281

A. Neurodegenerative disorders

A. Drzezga1, H. Barthel2; 1 Cologne/DE 2 Leipzig/DE

Learning Objectives

1. To learn about pathophysiology in neurodegenerative disorders.
2. To learn about different tracers and how to interpret the findings.
3. To understand the role of hybrid imaging in neurodegenerative disorders.

Abstract

Integrated PET/MRI systematically offers a complementary combination of two modalities which has often proven itself superior to the single modality approach in the diagnostic workup of neurodegenerative diseases. Emerging brain PET tracers, like amyloid or tau tracers, technical advances in multi-parametric brain MRI and obvious workflow advantages may enable brain PET/MRI to significantly improve diagnostics of dementia disorders and Parkinsonian syndromes. Moreover, simultaneous PET/MRI is well suited to study complex brain function in which fast fluctuations of brain signals (e.g. related to task processing or in response to pharmacological interventions) need to be monitored on multiple levels. Further, brain PET/MRI is considered the ideal tool for anti-neurodegenerative drug testing.

A-282

B. Brain tumours

J. McConathy; St. Louis/US

Learning Objectives

1. To get an overview of brain tumours and tracers used.
2. To learn how to interpret the examinations.
3. To understand the role of hybrid imaging of brain tumours.

Abstract

Neuroimaging with positron emission tomography (PET) and magnetic resonance imaging (MRI) plays a critical role in the diagnosis, treatment planning, and post-treatment evaluation of patients with primary and metastatic brain tumours. This presentation will discuss the use of molecular neuroimaging in conjunction with MRI for neuro-oncology. The use of [F-18]FDG and radiolabeled amino acids will be reviewed, and the potential applications of PET/MRI for brain tumour imaging will be presented.

A-283

C. Interactive case discussion (part 1)

A. Drzezga1, H. Barthel2; 1 Cologne/DE 2 Leipzig/DE

Learning Objectives

1. To learn about evaluation of hybrid imaging in neurodegenerative disorders.
2. To learn about evaluation of hybrid imaging of brain tumours.

Abstract

Integrated PET/MRI systematically offers a complementary combination of two modalities which has often proven itself superior to the single modality approach in the diagnostic workup of neurodegenerative diseases. In this presentation, interesting case examples of neurodegenerative disorders will be discussed. It will be demonstrated how combined PET/MRI simplifies and improves early and differential diagnosis.

A-284

C. Interactive case discussion (part 2)

J. McConathy; St. Louis/US

Learning Objectives

1. To learn about evaluation of hybrid imaging in neurodegenerative disorders.
2. To learn about evaluation of hybrid imaging of brain tumours.

Abstract

-

This website uses cookies. Learn more